ARV-110

ARV-110 · Arvinas Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ARV-110, covering 2025-04-01 to 2026-04-28. Get the full timeline:

Most recent: Clinical Trial Results: Trial of ARV-110 and Abiraterone in Participants With Metastatic Prostate Cancer [Phase 1]